AWM
Avior Wealth Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Hold |
7,561
| – | – | 0.05% | 241 |
|
|
2025
Q1 | $1.18M | Hold |
7,561
| – | – | 0.04% | 240 |
|
|
2024
Q4 | $1.04M | Sell |
7,561
-651
| -8% | -$89.6K | 0.04% | 279 |
|
|
2024
Q3 | $1.23M | Buy |
8,212
+240
| +3% | +$35.8K | 0.05% | 248 |
|
|
2024
Q2 | $1.09M | Buy |
7,972
+150
| +2% | +$20.5K | 0.05% | 255 |
|
|
2024
Q1 | $1.18M | Hold |
7,822
| – | – | 0.05% | 250 |
|
|
2023
Q4 | $985K | Buy |
7,822
+645
| +9% | +$81.2K | 0.06% | 210 |
|
|
2023
Q3 | $672K | Buy |
7,177
+814
| +13% | +$76.2K | 0.05% | 264 |
|
|
2023
Q2 | $568K | Buy |
6,363
+547
| +9% | +$48.8K | 0.04% | 307 |
|
|
2023
Q1 | $624K | Buy |
5,816
+287
| +5% | +$30.8K | 0.04% | 284 |
|
|
2022
Q4 | $675K | Buy |
5,529
+136
| +3% | +$16.6K | 0.05% | 240 |
|
|
2022
Q3 | $556K | Buy |
5,393
+24
| +0.4% | +$2.47K | 0.05% | 249 |
|
|
2022
Q2 | $499K | Hold |
5,369
| – | – | 0.05% | 252 |
|
|
2022
Q1 | $630K | Sell |
5,369
-882
| -14% | -$103K | 0.05% | 241 |
|
|
2021
Q4 | $840K | Buy |
6,251
+1,447
| +30% | +$194K | 0.07% | 227 |
|
|
2021
Q3 | $765K | Hold |
4,804
| – | – | 0.06% | 230 |
|
|
2021
Q2 | $631K | Buy |
4,804
+529
| +12% | +$69.5K | 0.06% | 251 |
|
|
2021
Q1 | $550K | Buy |
4,275
+1,008
| +31% | +$130K | 0.06% | 278 |
|
|
2020
Q4 | $544K | Buy |
3,267
+557
| +21% | +$92.7K | 0.07% | 247 |
|
|
2020
Q3 | $418K | Buy |
2,710
+170
| +7% | +$26.2K | 0.06% | 271 |
|
|
2020
Q2 | $375K | Buy |
2,540
+720
| +40% | +$106K | 0.06% | 292 |
|
|
2020
Q1 | $204K | Buy |
+1,820
| New | +$204K | 0.04% | 342 |
|